期刊
MOLECULAR THERAPY
卷 16, 期 8, 页码 1481-1489出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/mt.2008.92
关键词
-
资金
- NHLBI NIH HHS [R01 HL074704-05A2, R01 HL074704] Funding Source: Medline
- NIAID NIH HHS [R37 AI029329-20, R37 AI029329, R01 AI042552, R01 AI042552-11] Funding Source: Medline
The successful use of small interfering RNAs (siRNAs) for therapeutic purposes requires safe and efficient delivery to specific cells and tissues. In this study, we demonstrate cell type -specific delivery of anti-human immunodeficiency virus (anti-HIV) siRNAs through fusion to an antigp120 aptamer. The envelope glycoprotein is expressed on the surface of HIV-1-infected cells, allowing binding and internalization of the aptamer -siRNA chimeric molecules. We demonstrate that the anti-gp120 aptamer siRNA chimera is specifically taken up by cells expressing HIV-1 gp120, and that the appended siRNA is processed by Dicer; this releases an anti-tat/rev siRNA which, in turn, inhibits HIV replication. We show for the first time a dual functioning aptamer -siRNA chimera in which both the aptamer and the siRNA portions have potent anti-HIV activities. We also show that gp120 expressed on the surface of HIV-infected cells can be used for aptamermediated delivery of anti-HIV siRNAs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据